Antifibrotic potential of a selective COX-2 inhibitor (celecoxib) and a synthetic PPAR y ligand (pioglitazone) on liver fibrosis in Rats / Noha Samir Abdellatif ; Supervised Ahmed Hussein Galal , Fatma Ahmed Elbatrawi , Essam Fouad Alalkamy
Material type:
- التأثير المحتمل لمثبط كوكس ٢ الإنتقائى (سيليكوكسيب) و منشط ببار جاما الإصطناعي (بيوجليتازون) علي تليف الكبد في الجرذان [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.29.M.Sc.2011.No.A (Browse shelf(Opens below)) | Not for loan | 01010110055774000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.29.M.Sc.2011.No.A (Browse shelf(Opens below)) | 55774.CD | Not for loan | 01020110055774000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pharmacology
Chronic liver injury, independent of the cause, is generally associated with the accumulation of matrix proteins, a process referred to as fibrosis. Over the last decade liver fibrosis is no longer viewed as either passive or permanent but as a dynamic process and potential therapies continue to be identified. Hepatic stellate cells (HSCs) play a critical role in the fibrogenesis of liver, so they are the target cells of antifibrotic therapy
Issued also as CD
There are no comments on this title.